Table 1.
Demographic characteristics of 79 MSM included in the study on rectal cytokines and Chlamydia trachomatis infection, Amsterdam, 2010 to 2011a
| Participant characteristics | Values by infection status, group, HIV status, and cART use |
|||||
|---|---|---|---|---|---|---|
|
C. trachomatis negative |
C. trachomatis positive |
|||||
| Group A, HIV− | Group B, HIV+ cART− | Group C, HIV+ cART+ | Group D, HIV− | Group E, HIV+ cART− | Group F, HIV+ cART+ | |
| No. | 15 | 13 | 19 | 15 | 8 | 9 |
| Demographics | ||||||
| Age (median [IQR]) (yr) | 40 (27–48) | 40 (33–46) | 46 (42–49) | 33 (29–43) | 36 (30–40) | 43 (29–52) |
| Ethnicity (no. [%]) | ||||||
| Dutch | 11 (73) | 11 (85) | 17 (89) | 11 (73) | 4 (50) | 7 (89) |
| Other | 4 (27) | 2 (15) | 2 (10) | 4 (27) | 4 (50) | 2 (11) |
| Anal symptoms (no. [%]) | ||||||
| No | 15 (100) | 13 (100) | 18 (95) | 14 (93) | 7 (88) | 7 (78) |
| Yes | 0 | 0 | 1 (5) | 1 (7) | 1 (13) | 2 (22) |
| HIV clinical data | ||||||
| HIV plasma viral load (median [IQR]) (copies/ml) | 1,930 (310–29,319)b | 20 (20–20) | 14,500 (10,000–254,000)c | 20 (20–20)d | ||
| HIV plasma viral load (no. [%]) | ||||||
| <50 copies/ml | 1 (8) | 19 (100) | 0 | 7 (78) | ||
| ≥50 copies/ml | 5 (39) | 0 | 3 (38) | 0 | ||
| Data missing | 7 (54) | 0 | 5 (63) | 2 (22) | ||
| CD4+ T cells (median [IQR]) (cells/mm3) | 735 (400–880)b | 534 (430–690) | 460 (440–940)c | 670 (430–700)d | ||
| CD4+ T cells (no. [%]) | ||||||
| <200 cells/mm3 | 0 | 1 (5) | 0 | 0 | ||
| ≥200 cells/mm3 | 6 (46) | 18 (95) | 3 (38) | 7 (78) | ||
| Data missing | 7 (54) | 0 | 5 (62) | 2 (22) | ||
a
MSM, men who have sex with men; cART, combination antiretroviral therapy; IQR, interquartile range.
b
Based on 6 participants with available test results.
c
Based on 3 participants with available test results.
d
Based on 7 participants with available test results.